Stockscreener 앱 받기
169.12
1.46%
2.44
전일 마감가:
$166.68
열려 있는:
$167.12
하루 거래량:
532.03K
Relative Volume:
1.09
시가총액:
$5.43B
수익:
$560.03M
순이익/손실:
$-150.66M
주가수익비율:
-34.80
EPS:
-4.86
순현금흐름:
$-87.43M
1주 성능:
+5.32%
1개월 성능:
+26.79%
6개월 성능:
+41.59%
1년 성능:
+142.15%
1일 변동 폭
$166.51
$172.59
1주일 범위
$152.05
$172.59
52주 변동 폭
$55.92
$172.59
Irhythm Technologies Inc Stock (IRTC) Company Profile
명칭
Irhythm Technologies Inc
전화
415-632-5700
주소
699 8TH STREET, San Francisco, CA
IRTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
169.12 | 5.07B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | 재개 | Wells Fargo | Equal Weight |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-06-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-02-07 | 개시 | Wells Fargo | Overweight |
| 2022-11-07 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-06 | 개시 | Wolfe Research | Underperform |
| 2022-02-24 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-18 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-12-21 | 재개 | Canaccord Genuity | Buy |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-06-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-04-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-04-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Colliers Securities | Buy → Neutral |
| 2021-01-29 | 재확인 | Needham | Hold |
| 2020-11-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-11 | 개시 | Needham | Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-08-07 | 업그레이드 | Colliers Securities | Neutral → Buy |
| 2020-08-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-10 | 개시 | William Blair | Outperform |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-10-22 | 개시 | Oppenheimer | Perform |
| 2019-02-20 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | 재확인 | Canaccord Genuity | Buy |
| 2018-09-06 | 개시 | Chardan Capital Markets | Buy |
| 2018-08-02 | 업그레이드 | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | 다운그레이드 | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | 개시 | Dougherty & Company | Neutral |
모두보기
Irhythm Technologies Inc 주식(IRTC)의 최신 뉴스
iRhythm Technologies to Participate in Upcoming Investor Conferences - The Manila Times
Digital Health Leader iRhythm Technologies Set for Wells Fargo, Morgan Stanley, Baird Conferences - Stock Titan
iRhythm up on Buy coverage at BofA on market expansion opportunities - Seeking Alpha
IRhythm Technologies' Zio MCT to Serve as Catalyst for Market Share Gains, BofA Says - MarketScreener
B of A Securities initiates coverage on iRhythm Technologies with a Buy rating, PT $200. - AInvest
This Figma Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
Morgan Stanley Raises iRhythm (IRTC) Price Target, Maintains Overweight Rating - MSN
iRhythm Technologies (IRTC) Surpasses Q2 Revenue Forecasts, Raises Outlook - MSN
iRhythm Technologies Exceeds Q2 Revenue Forecasts, Raises Full-Year Outlook - AInvest
AVALON Study Builds on CAMELOT Study Reinforcing iRhythm’s LTCM Clinical Performance - Diagnostic and Interventional Cardiology
iRhythm Technologies falls after Spruce Point issues short-selling report - TradingView
Investor Short Report Flags Steep Downside Risk For iRhythm Technologies - Benzinga
Spruce Point issues strong sell report on iRhythm Technologies - MarketScreener
Spruce Point says it’s short iRhythm, sees 40%-70% potential LT downside - TipRanks
Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on iRhythm Technologies (NASDAQ: IRTC) - Business Wire
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority - The Manila Times
428,707-Patient Study: iRhythm's Heart Monitor Doubles Diagnosis Rate, Cuts Healthcare Costs by $816/Patient - Stock Titan
AI Tracker: Vendor says AI model gets 100% score on medical exam - Modern Healthcare
iRhythm Technologies Inc. Crosses 200 Day MA — Signal or Noise2025 Technical Patterns & Fast Entry and Exit Trade Plans - sundaytimes.kr
Introducing the CSO finalists in our C-Suite Leaders Awards - The Business Journals
Published on: 2025-08-14 23:53:49 - classian.co.kr
ECG Patch and Holter Monitor Market Set to Witness Significant - openPR.com
Alignment Healthcare, Bio-Techne, Envista, iRhythm, and UFP Technologies Shares Skyrocket, What You Need To Know - Yahoo Finance
Local health-tech startup secures $2.3M to accelerate AI tools, double workforce - The Business Journals
IRTC Q2 Deep Dive: Core Business Momentum and Product Expansion Shape Outlook - Yahoo Finance
Artificial Intelligence in Remote Patient Monitoring Market - openPR.com
Artificial Intelligence in Remote Patient Monitoring Market Poised to Grow at 27.13% CAGR Through 2032, Reports DelveInsight | Medtronic, iRhythm, Philips, Siemens Healthineers, GE HealthCare, etc - Barchart.com
Morgan Stanley Maintains Buy Rating for Irhythm Technologies with $195 Price Target - AInvest
Chad Patterson Sells 2,555 Shares of iRhythm Technologies Inc, Modestly Overvalued According to GF Value - AInvest
Don't Ignore The Insider Selling In iRhythm Technologies - simplywall.st
iRhythm Technologies' Chief Commercial Officer Sells 2,555 Shares - AInvest
iRhythm Fails to Halt Information Exchange in Investor Lawsuit - Bloomberg Law News
Top Executives Cash Out Big on Irhythm Technologies Stock! - TipRanks
Top Executives Cash Out on Irhythm Technologies Stock Amid Strong Earnings and Raised Price Targets. - AInvest
Stewart Won't Reconsider Her 1st Settled Expectations Denial - Law360
Stewart Denies iRhythm’s Bid to Review Decision Scrapping IPRs Based on ‘Settled Expectations’ - IPWatchdog.com
Insider Selling at iRhythm Technologies: Signal or Noise in a High-Flying Stock? - AInvest
Truist Financial Sticks to Their Buy Rating for Irhythm Technologies (IRTC) - The Globe and Mail
Truist Financial Reiterates Buy Rating for Irhythm Technologies with $175 Price Target - AInvest
iRhythm Technologies Sees Boosted Price Target Following Strong Earnings - AInvest
Why Are iRhythm Technologies Shares Dropping? - TipRanks
Is It Too Late To Consider Buying IRhythm Technologies, Inc. (NASDAQ:IRTC)? - 富途牛牛
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
What is the risk reward ratio of investing in iRhythm Technologies Inc. stockMaximize portfolio growth with strategic plans - Jammu Links News
What analysts say about iRhythm Technologies Inc. stockRapidly growing investment returns - Jammu Links News
How strong is iRhythm Technologies Inc. company’s balance sheetCapitalize on momentum-driven stocks - Jammu Links News
iRhythm’s Strategic Moves and Strong Q2 Performance Boost Stock - StocksToTrade
When is iRhythm Technologies Inc. stock expected to show significant growthUnlock superior stock analysis tools - Jammu Links News
How volatile is iRhythm Technologies Inc. stock compared to the marketTap into rapid wealth building techniques - Jammu Links News
Is iRhythm Technologies Inc. a growth stock or a value stockExponential return rates - Jammu Links News
What catalysts could drive iRhythm Technologies Inc. stock higher in 2025Achieve consistent profits with proven strategies - Jammu Links News
Irhythm Technologies Inc (IRTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Irhythm Technologies Inc 주식 (IRTC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| TALWALKAR ABHIJIT Y | Director |
Aug 11 '25 |
Option Exercise |
10.71 |
5,312 |
56,892 |
25,611 |
| TALWALKAR ABHIJIT Y | Director |
Aug 11 '25 |
Sale |
158.02 |
5,312 |
839,381 |
20,299 |
0.89%
자본화:
|
볼륨(24시간):